This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CAHG And Diaceutics Partner To Develop Marketing And Communication Campaigns Specific To Personalized Healthcare





NEW YORK, April 30, 2013 /PRNewswire/ -- Diaceutics Limited, a leading personalized healthcare consultancy, and CAHG, a leading professional healthcare communications company, today announced a strategic partnership to develop marketing campaigns specific to personalized healthcare. This value-enhancing marketing service will enable pharmaceutical companies to comprehensively plan and execute global marketing campaigns relevant to targeted therapy and molecular diagnostics.

(Logo:  http://photos.prnewswire.com/prnh/20120328/CG76467LOGO)

"The strategic alliance with Diaceutics fits with our overall goal to accelerate the adoption of personalized healthcare into clinical practice," said Scott Cotherman, President and CEO, CAHG and Chairman, TBWA\WorldHealth. "Together we can offer strategies and tactical implementation, from consulting through communication, to help clients realize the promise of personalized healthcare for all stakeholders. Our joint services will be available in the second quarter of 2013."

Diaceutics and CAHG joined forces over the last 12 months to identify clinical and communication gaps, as well as the opportunities arising in the emerging personalized healthcare field. A recently completed study with 400 physicians in the U.S. and EU conducted by CAHG and the Adelphi Group illustrates the opportunity to re-engineer the traditional approach to pharmaceutical marketing and integrate it with the value proposition of personalized healthcare to improve clinical outcomes. 

"We are delighted to partner with CAHG, leverage their marketing expertise, and in turn help our pharmaceutical and diagnostic clients create personalized healthcare-specific brands," said Peter Keeling, CEO, Diaceutics. "Personalized healthcare marketing brings its own unique set of challenges in terms of education and multiple stakeholder involvement. However, we believe this represents a significant opportunity for our clients to take a fresh approach to pharmaceutical marketing, away from the one-size-fits-all message towards educational programs that aid the patient journey and help physicians select the tests and treatments best suited to those patients. The right treatment for the right patient begins with the right knowledge."



1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,034.93 +208.63 1.17%
S&P 500 2,100.40 +19.22 0.92%
NASDAQ 4,994.6020 +62.7870 1.27%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs